CAMLINFINE
Camlin Fine share price & financials
- Price
- ₹140.28
- Market cap
- ₹2.1k Cr
- Sector
- Chemicals
- Calls analysed
- 8
Camlin Fine Q1 FY27
What went well
- Overall revenues of ₹519.9 crores (INR 5,199 million), up ~28% YoY and almost ₹100 crores QoQ.
- Specialty Ingredient business generated >₹400 crores (INR 4,000 million) in revenue, maintaining a 20% run rate.
- Achieved 95% customer approval for ethyl vanillin, indicating successful product ramp-up despite initial caution.
What to watch
- Overall EBITDA margins compressed significantly to 4% in Q1 FY27 from +45% last quarter, mainly due to high raw material and freight costs.
- Aroma segment recorded a negative burn of ₹4-4.5 crores, attributed to low capacity utilization (25%) during the ethyl vanillin campaign.
What Camlin Fine does
Camlin Fine Sciences manufactures specialty chemicals across four lines: antioxidants (Straights) and forward-integrated antioxidant blends used to extend shelf life in food, feed and pet food; performance chemicals derived from hydroquinone and catechol used in petrochemicals, dyes, polymers and agrochemicals; and aroma ingredients, chiefly vanillin and ethyl vanillin, sold into food, flavours & fragrances and pharma. The company runs a vertically integrated chemistry chain (phenol into hydroquinone/catechol into downstream derivatives), captively consuming intermediates to feed its own Straights, Performance Chemicals and Aroma Ingredients businesses. It operates through regional units in India, Mexico, Brazil and North America, plus recently acquired natural-ingredients businesses Vitafor and Vinpai (France), serving customers across food & beverage, animal nutrition, pharmaceuticals, agrochemicals and personal care industries worldwide.
Segments
- Specialty Ingredients (Straights)
- Specialty Ingredients (Value Added Blends)
- Performance Chemicals
- Aroma Ingredients
- Global manufacturing facilities
- 8
- Application laboratories
- 7
- R&D centres
- 2
- Country presence
- 80+
- Integrated global production capacity
- 49,000+
- Product range
- 100+ diversified product offerings
Guidance record · Q1 FY27
what the last two calls moved 27 tracked 0 delivered 14 missed 13 open- Blends Business Growth Rate missed said Q2 FY25 Promised: 20% per year for the next couple of years Q1 FY27: Historical promise, missed in FY26. Focus has shifted to new FY27 targets for the broader 'Specialty Ingredients' segment.
- Vanillin Volume revised down said Q3 FY26 Promised: 4,000 metric tons in FY27 Q1 FY27: So basically, we had guided for 3,600 to 4,000 and now we are saying 3,000 around 3,000. The change is due to a slower ramp-up of ethyl vanillin for quality assurance.
- Blends Business Growth on track said Q3 FY26 Promised: 25% growth over FY26 Q1 FY27: Management guided for 20-30% growth in the Specialty Ingredients segment for FY27, which includes the blends business, keeping the original target in range.
All 27 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue up 16.2%, net profit down 9.1% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 227 | 205 | 273 | 191 | 244 +7% | 219 +7% | 184 −33% | 222 +16% |
| EBITDA | 14 | 16 | 33 | 5 | 18 +29% | 19 +19% | 6 −82% | 7 +40% |
| Net profit | -73 | -6 | 16 | -11 | -4 +95% | -13 −117% | -6 −137% | -12 −9% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −52.8% 1Y
1Y: ₹215.31 on 10 Sept 2025 → ₹101.68. High ₹231.02 (17 Sept 2025), low ₹96.93 (30 Mar 2026).
How the price took the results
close before → close after
- Q1 FY27
- +0.9%
- 11 Aug
- Q4 FY26
- −1.0%
- 26 May
- Q3 FY26
- −2.1%
- 13 Feb
- Q2 FY26
- −3.9%
- 10 Nov
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue fell 20.7% a year over 3 years, FY23 to FY26. Operating margin narrowed to 5.7%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹1.7k Cr | ₹773 Cr | ₹887 Cr | ₹838 Cr |
| Operating profit | ₹196 Cr | ₹26 Cr | ₹70 Cr | ₹48 Cr |
| Operating margin | 11.7% | 3.4% | 7.9% | 5.7% |
| Interest | ₹59 Cr | ₹54 Cr | ₹66 Cr | ₹67 Cr |
| Depreciation | ₹62 Cr | ₹49 Cr | ₹52 Cr | ₹53 Cr |
| Net profit | ₹40 Cr | ₹-51 Cr | ₹-77 Cr | ₹-34 Cr |
| Net margin | 2.4% | -6.6% | -8.7% | -4.1% |
| Cash from operations | ₹19 Cr | ₹82 Cr | ₹18 Cr | ₹44 Cr |
| Free cash flow | ₹-113 Cr | ₹41 Cr | ₹-4 Cr | ₹17 Cr |
| ROCE | 11.0% | 0.0% | 4.0% | 3.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹13 Cr | ₹16 Cr | ₹16 Cr | ₹17 Cr | ₹19 Cr | ₹19 Cr |
| Reserves | ₹452 Cr | ₹577 Cr | ₹626 Cr | ₹699 Cr | ₹871 Cr | ₹910 Cr |
| Borrowings | ₹378 Cr | ₹461 Cr | ₹617 Cr | ₹511 Cr | ₹672 Cr | ₹482 Cr |
| Other liabilities | ₹224 Cr | ₹293 Cr | ₹335 Cr | ₹345 Cr | ₹476 Cr | ₹361 Cr |
| Total liabilities | ₹1.1k Cr | ₹1.3k Cr | ₹1.6k Cr | ₹1.6k Cr | ₹2.0k Cr | ₹1.8k Cr |
| Fixed assets | ₹294 Cr | ₹304 Cr | ₹583 Cr | ₹577 Cr | ₹700 Cr | ₹526 Cr |
| Capital work in progress | ₹18 Cr | ₹207 Cr | ₹28 Cr | ₹31 Cr | ₹15 Cr | ₹23 Cr |
| Investments | ₹74 Cr | ₹82 Cr | ₹82 Cr | ₹80 Cr | ₹69 Cr | ₹217 Cr |
| Other assets | ₹681 Cr | ₹753 Cr | ₹901 Cr | ₹884 Cr | ₹1.3k Cr | ₹1.0k Cr |
| Total assets | ₹1.1k Cr | ₹1.3k Cr | ₹1.6k Cr | ₹1.6k Cr | ₹2.0k Cr | ₹1.8k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, FIIs trimmed −1.97 pp while the public added +1.75 pp. The shareholder count shrank 7% to 55,178.
- Promoters
- 48.0%
- FIIs
- 0.9%
- DIIs
- 5.4%
- Public
- 45.6%
Since Jun 2025
- FIIs −1.97 pp
- Public +1.75 pp
- DIIs +1.28 pp
How it drifted, 12 quarters
Over this window DIIs went from 3.9% to 5.4% — +1.5 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 48.0%, FIIs 1.6%, DIIs 3.9%, Public 46.5%.Dec '23: Promoters 48.0%, FIIs 1.0%, DIIs 3.8%, Public 47.2%.Mar '24: Promoters 48.0%, FIIs 1.7%, DIIs 4.5%, Public 45.7%.Jun '24: Promoters 48.0%, FIIs 1.0%, DIIs 4.9%, Public 46.1%.Sep '24: Promoters 48.0%, FIIs 0.8%, DIIs 4.2%, Public 46.9%.Dec '24: Promoters 48.0%, FIIs 0.8%, DIIs 3.4%, Public 47.8%.Mar '25: Promoters 49.1%, FIIs 1.5%, DIIs 3.8%, Public 45.6%.Jun '25: Promoters 49.1%, FIIs 2.9%, DIIs 4.1%, Public 43.9%.Sep '25: Promoters 49.1%, FIIs 2.1%, DIIs 5.5%, Public 43.3%.Dec '25: Promoters 48.0%, FIIs 2.1%, DIIs 7.8%, Public 42.1%.Mar '26: Promoters 48.0%, FIIs 0.9%, DIIs 7.7%, Public 43.3%.Jun '26: Promoters 48.0%, FIIs 0.9%, DIIs 5.4%, Public 45.6%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Camlin Fine above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Ashish Subhash Dandekar | 10.30% | unchanged |
| Infinity Direct Holdings | 10.18% | unchanged |
| Anfima Nv | 8.83% | unchanged |
| Infinity Portfolio Holdings FPI fund | 6.20% | unchanged |
| Infinity Direct Capital FPI fund | 4.82% | unchanged |
| ICICI Prudential Commodities Fund Mutual fund | 4.77% | unchanged |
| Camart Finance Limited | 2.77% | unchanged |
| Nirmal Vinod Momaya | 1.88% | unchanged |
| Anagha Subhash Dandekar | 1.57% | unchanged |
| Vibha Agencies Pvt Ltd | 1.36% | unchanged |
| Ajay Upadhyaya | 1.30% | unchanged |
| Infinity Portfolio Holdings | 1.17% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
All earnings calls (8)
Read the Q1 FY27 call →Learn to analyse Camlin Fine
Guides on how to read this kind of business and the numbers that matter.